Listed

Standard Biotools Inc.: Form 10-Q for the period ended Sep 30, 2017

Filed with the SEC on Nov 7, 2017 and accepted by EDGAR at Nov 7, 2017, 17:19 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2017-07-01 to 2017-09-30$11.4mus-gaap:CostOfGoodsSold
Cost of revenue9 months2017-01-01 to 2017-09-30$33.1mus-gaap:CostOfGoodsSold
Research and development3 months2017-07-01 to 2017-09-30$7.7mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2017-01-01 to 2017-09-30$23.7mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2017-07-01 to 2017-09-30$20.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2017-01-01 to 2017-09-30$63.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-07-01 to 2017-09-30−$15.6mus-gaap:OperatingIncomeLoss
Operating income9 months2017-01-01 to 2017-09-30−$49.6mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-07-01 to 2017-09-30$1.5mus-gaap:InterestExpense
Interest expense9 months2017-01-01 to 2017-09-30$4.4mus-gaap:InterestExpense
Income tax3 months2017-07-01 to 2017-09-30−$735.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2017-01-01 to 2017-09-30−$3.3mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-07-01 to 2017-09-30−$15.9mus-gaap:NetIncomeLoss
Net income9 months2017-01-01 to 2017-09-30−$50.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-07-01 to 2017-09-30−$0.46us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2017-01-01 to 2017-09-30−$1.61us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2017-01-01 to 2017-09-30−$24.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2017-01-01 to 2017-09-30$1.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2017-09-30$60.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-09-30$96.2mus-gaap:AssetsCurrent
Total assetsAt period end2017-09-30$292.0mus-gaap:Assets
Current liabilitiesAt period end2017-09-30$31.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-09-30$252.9mus-gaap:Liabilities
Shareholders' equityAt period end2017-09-30$39.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001162194-17-000159. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.